Article
G0S2 is an all-trans-retinoic acid target gene
1 Jan 1992
Abstract excerpt
All-trans-retinoic acid (RA) treatment of acute promyelocytic leukemia (APL) cases expressing the t(15;17) product, PML/RARalpha, is a successful example of differentiation therapy. Uncovering RA target genes is of considerable interest in APL. This study comprehensively examines in APL cells transcriptional and post-transcriptional regulation of the novel candidate RA target gene, G0S2, the G0/G1 switch gene....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
